191217-81-9

  • Product Name:Pramipexole
  • Molecular Formula:C10H21Cl2N3OS
  • Purity:99%
  • Molecular Weight:302.268
Inquiry

Product Details

pd_meltingpoint:290 °C(dec.)

Appearance:gray white crystalline powder

Hot Sale, Top quality Pramipexole 191217-81-9, good supplier

  • Molecular Formula:C10H17N3S*2ClH*H2O
  • Molecular Weight:302.268
  • Appearance/Colour:gray white crystalline powder 
  • Vapor Pressure:9.93E-11mmHg at 25°C 
  • Melting Point:290 °C(dec.) 
  • Boiling Point:378 °C at 760 mmHg 
  • Flash Point:182.4 °C 
  • PSA:88.41000 
  • LogP:4.09400 

Top quality Pramipexole 191217-81-9 Usage

White or almost white, crystalline powder. Pramipexole is a unique compound in its therapeutic potential. It is approved to treat signs and symptoms of idiopathic Parkinson’s disease and moderate to severe symptoms of primary restless leg syndrome.

 

InChI:InChI=1/C10H17N3S.2ClH.H2O/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8;;;/h7,12H,2-6H2,1H3,(H2,11,13);2*1H;1H2

Pramipexole 191217-81-9 Relevant articles

Precise Dosing of Pramipexole for Low-Dosed Filament Production by Hot Melt Extrusion Applying Various Feeding Methods

Rebecca Chamberlain ,Hellen Windolf ,Simon Geissler ,Julian Quodbach  and Jörg Breitkreutz

Pharmaceutics 2022, 14(1), 216

It was found that deviation from target pramipexole concentration occurred due to degradation products in bPMMA formulations. Additionally, material temperature above 120 °C led to the formation of the anhydrous form of pramipexole within the extruded filaments and need to be considered in the calculation of the recovered API.

Direct and sensitive electrochemical evaluation of pramipexole using graphitic carbon nitride (gCN) sensor

Yogesh M. Shanbhag ,Mahesh M. Shanbhag ,Shweta J. Malode ,S. Dhanalakshmi ,Kunal Mondal  andNagaraj P. Shetti

Biosensors 2022, 12(8), 552

Pramipexole (PMXL) belongs to the benzothiazole class of aromatic compounds and is used in treating Parkinson’s disease; however, overdosage leads to some abnormal effects that could trigger severe side effects.

Pramipexole 191217-81-9 Process route

(S)?2?amino?6?propionamido?4,5,6,7?tetrahydrobenzothiazole
106006-84-2

(S)?2?amino?6?propionamido?4,5,6,7?tetrahydrobenzothiazole

pramipexole dihydrochloride monohydrate
191217-81-9,908244-04-2

pramipexole dihydrochloride monohydrate

Conditions
Conditions Yield
(S)?2?amino?6?propionamido?4,5,6,7?tetrahydrobenzothiazole; With sodium tetrahydroborate; sulfuric acid; In tetrahydrofuran; at 10 ℃; for 2h;
With hydrogenchloride; Reagent/catalyst;
97.6%
pramipexole
104632-26-0

pramipexole

pramipexole dihydrochloride monohydrate
191217-81-9,908244-04-2

pramipexole dihydrochloride monohydrate

Conditions
Conditions Yield
With hydrogenchloride; water; In isopropyl alcohol; at 20 ℃; for 3h; Product distribution / selectivity;
90%
With hydrogenchloride; water; In ethanol; at 25 - 40 ℃;
 

191217-81-9 Upstream products

  • 104632-26-0
    104632-26-0

    pramipexole

  • 943319-02-6
    943319-02-6

    2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole p-toluenesulfonic acid

  • 104632-25-9
    104632-25-9

    pramipexole dihydrochloride

  • 106006-84-2
    106006-84-2

    (S)?2?amino?6?propionamido?4,5,6,7?tetrahydrobenzothiazole

Relevant Products